Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

IQVIA Holdings Inc - Key Facts

IQVIA Holdings Inc - Key Employees

IQVIA Holdings Inc - Key Employee Biographies

IQVIA Holdings Inc - Major Products and Services

IQVIA Holdings Inc - History

IQVIA Holdings Inc - Company Statement

IQVIA Holdings Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

IQVIA Holdings Inc - Business Description

Business Segment: Commercial Solutions

Overview

Performance

Business Segment: Integrated Engagement Services

Overview

Performance

Business Segment: Research & Development Solutions

Overview

Performance

Geographical Segment: Americas

Performance

Geographical Segment: Asia-Pacific

Performance

Geographical Segment: Europe and Africa

Performance

IQVIA Holdings Inc - Corporate Strategy

IQVIA Holdings Inc - SWOT Analysis

SWOT Analysis - Overview

IQVIA Holdings Inc - Strengths

IQVIA Holdings Inc - Weaknesses

IQVIA Holdings Inc - Opportunities

IQVIA Holdings Inc - Threats

IQVIA Holdings Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

IQVIA Holdings Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Feb 04, 2019: IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

Feb 04, 2019: IQVIA launches IQVIA Biotech, dedicated to emerging biotech and biopharma industry

Jan 30, 2019: IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019

Dec 06, 2018: IQVIA Named Best Contract Research Organization Full-Service Provider in 2018 Scrip Awards

Nov 29, 2018: IQVIA s OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency

Nov 27, 2018: IQVIA s orchestrated customer engagement selected by Novo Nordisk international operations

Nov 27, 2018: IQVIAs orchestrated customer engagement selected by Novo Nordisk international operations

Nov 20, 2018: Adhera Therapeutics selects IQVIA’s OCE technology platform to support commercial excellence

Oct 30, 2018: Public Release: 30-Oct-2018 Life-changing intersection between big data and therapeutic pipeline in neuromuscular disease MWW Group A new report funded by the Muscular Dystrophy Association (MDA) and released by the IQVIA Institute for Human Data Science

Oct 18, 2018: Xeloda Adherence Support App Contributes to Improving Communication between Cancer Patients and Healthcare Providers

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The company offers a wide range of solutions in clinical development, commercialization and technologies, and helps stimulate significant healthcare outcomes. Its IQVIA CORE is a customized solution that provides actionable insights through big data, transformative technology and analytics with wide industry knowledge in diseases, regions, human behaviors and scientific advances. IQVIA serves biotech, medical device and pharmaceutical companies; medical researchers, government agencies, patient associations, payers and investigators, among others. The company has operations in Asia, Europe, the Americas, the Middle East and Africa. IQVIA is headquartered in Durham, North Carolina, the US.

IQVIA Holdings Inc Key Recent Developments

Feb 04,2019: IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
Jan 31,2019: IQVIA Launches Next Generation Site Portal Technology Capabilities to Streamline Clinical Trial ...
Jan 30,2019: IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019
Jan 19,2019: Iqvia launches new division to support emerging biotech market

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company